Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers. [electronic resource]
Producer: 20150731ISSN:- 1460-2105
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Biomarkers, Tumor -- metabolism
- Blotting, Western
- Cell Line, Tumor
- Cisplatin -- administration & dosage
- Cystadenocarcinoma, Serous -- drug therapy
- DNA Damage -- drug effects
- DNA, Neoplasm -- drug effects
- Drug Synergism
- Epithelial-Mesenchymal Transition
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- HeLa Cells
- Humans
- Immunohistochemistry
- Kaplan-Meier Estimate
- Mice
- Mice, Nude
- MicroRNAs -- metabolism
- Microscopy, Fluorescence
- Neoplasm Grading
- Neoplasm Transplantation
- Neoplasms, Experimental
- Odds Ratio
- Ovarian Neoplasms -- drug therapy
- Phthalazines -- administration & dosage
- Piperazines -- administration & dosage
- Poly(ADP-ribose) Polymerase Inhibitors
- Rad51 Recombinase -- drug effects
- Real-Time Polymerase Chain Reaction
- Tissue Array Analysis
- Tumor Stem Cell Assay
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.